Israeli health-tech startup secures $1.6M grant for revolutionary at-home fertility device
Summary
IMMA Health secured a $1.6 million grant from the Israel Innovation Authority and earned the European Innovation Council’s Seal of Excellence. The company is building a self-operated transvaginal ultrasound platform that combines robotics and AI for at-home fertility monitoring. It plans to use the funding to accelerate development, run clinical trials, and prepare for regulatory approvals in the US and Europe. The technology could expand access to reproductive care and eventually support earlier detection of other women’s health conditions.
Funding
Amount
$2.5M
Total raised
Date
August 22, 2025
Announcement date
Investors
Israel Innovation Authority
Lead investors
Company
https://www.imma.health
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected